Department of Surgery and Integrated Clinic, Araçatuba Dental School, São Paulo State University, Rua José Bonifácio, 1193, Vila Mendonça, Aracatuba, SP, 16015-050, Brazil.
Department of Basic Sciences, Araçatuba Dental School, São Paulo State University, Araçatuba, SP, Brazil.
Osteoporos Int. 2020 Sep;31(9):1807-1815. doi: 10.1007/s00198-020-05431-y. Epub 2020 May 7.
This study evaluated the peri-implant bone repair in orchiectomized rats receiving intermittently PTH 1-34. The treatment returned the bone quality and quantity of the animals to normal in the computerized microtomography, laser confocal microscopy, and histological analysis. The PTH 1-34 promoted marked bone formation with increased volume, improved quality, and greater bone turnover.
Osteoporosis can be a problem in implant osseointegration. So this study aimed to evaluate the quantity and quality of peri-implant bone repair in orchiectomized Wistar rats receiving intermittently administered PTH 1-34.
Animals (n = 24) were divided into 3 groups: healthy control (SHAM), orchiectomized (ORQ), and orchiectomized and treated with 0.5 μg/kg/day PTH 1-34 (TERI), and each received an implant in the right and left tibial metaphysis, which was allowed to repair for 60 days. The resultant bone formation was evaluated through computerized microtomography (micro-CT) to compare the percent bone volume (BV/TV), trabecular thickness (Tb.Th), trabecular number and separation (Tb.N, Tb.Sp), and bone implant contact (BIC) through the intersection surface (i.S) between groups. Laser confocal microscopy was used to evaluate fluorochrome areas for mineral apposition rate (MAR) and neoformed bone area (NBA). In addition, histological evaluation of calcified tissues with Stevenel blue and alizarin red staining was performed.
Treatment with PTH 1-34 returned the bone quality and quantity of the osteoporotic animal to normal, as the TERI group presented statistically significant higher values for BV/TV, Tb.Th, and BIC parameters compared with ORQ (p < 0.05), but when compared with SHAM (p > 0.05), no statistical difference was noted. In addition, in the bone turnover analysis (MAR, NBA) for TERI, the highest results are presented, followed by SHAM, and then ORQ (TERI × ORQ: p < 0.05).
Intermittent treatment with PTH 1-34 on orchiectomized animals promoted marked bone formation with increased volume, improved quality, and greater bone turnover in the peri-implant space, returning the bone quality and quantity to the present standard in healthy animals.
评估间歇给予甲状旁腺素 1-34 对去势大鼠种植体周围骨修复的数量和质量。
动物(n=24)分为 3 组:健康对照组(SHAM)、去势组(ORQ)和去势+0.5μg/kg/天甲状旁腺素 1-34 治疗组(TERI),每组右侧和左侧胫骨干骺端植入种植体,允许修复 60 天。通过计算机微断层扫描(micro-CT)比较各组之间的骨体积分数(BV/TV)、骨小梁厚度(Tb.Th)、骨小梁数量和分离度(Tb.N、Tb.Sp)和骨-种植体接触(BIC),通过交界面(i.S)进行比较。激光共聚焦显微镜用于评估矿化沉积率(MAR)和新形成骨面积(NBA)的荧光标记区域。此外,采用 Stevenel 蓝和茜素红染色对钙化组织进行组织学评价。
PTH 1-34 治疗使骨质疏松动物的骨质量和数量恢复正常,TERI 组的 BV/TV、Tb.Th 和 BIC 等参数均显著高于 ORQ 组(p<0.05),但与 SHAM 组相比(p>0.05)无统计学差异。此外,在 TERI 的骨转换分析(MAR、NBA)中,结果最高,其次是 SHAM,然后是 ORQ(TERI×ORQ:p<0.05)。
间歇给予甲状旁腺素 1-34 治疗去势动物可促进种植体周围明显的骨形成,增加体积,改善质量,增加骨转换,使骨质量和数量恢复到健康动物的现有标准。